A semaglutida um anlogo do GLP-1, um hormnio produzido naturalmente no intestino e que atua na regulao dos nveis de acar no sangue, alm de promover a sensao de saciedade
Remember the previously mentioned GLP-1 receptor agonist and the GLP-1 hormone it mimics
[4] Conditions that match a drugs FDA approval generally qualify, whether youre using these major GLP-1 brands or similar: Ozempic/Mounjaro: type 2 diabetes [5] Wegovy/Zepbound: obesity (BMI 30) [6] Wegovy/Zepbound: overweight with at least one weight-related condition (BMI 27 to under 30 plus hypertension, high cholesterol, sleep apnea, cardiovascular disease, or type 2 diabetes) [7] Zepbound: obstructive sleep apnea [8] Wegovy: metabolic-associated steatohepatitis (MASH) [9] Off-label conditions can count too when your clinician documents a real diagnosis such as prediabetes, binge eating disorder, or PCOS
[PMC free article: PMC6444791] [PubMed: 22166753] 63
The critical point is tradeoffs: for many patients, improved glycemic control and sustained weight loss lower long-term cardiovascular risk
